Searched for
EMCURE PHARMA NEWS
Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...- Stocks in news: Paytm, Bajaj Auto, L&T, Bharti Airtel, Hero MotoCorpMarkets closed lower amid global headwinds and geopolitical worries. Several companies like Paytm, Bajaj Auto, and L&T are in focus due to ...
- Stocks in news: RIL, Tata Power, JSW Energy, HCL Tech, Inox GreenIndian markets climbed for a sixth day, with Nifty nearing 26,013. Investors watch global cues amid US market volatility. RIL's beauty arm ...
- Emcure Pharma, Info Edge among 4 stocks that formed White Marubozu Pattern on July 22A White Marubozu is a bullish candlestick pattern that forms when the opening price is the lowest and the closing price is the highest for ...
- Stocks in news: Axis Bank, Tech Mahindra, Wipro, LTIMindtree, Angel OneMarkets remained range-bound due to lack of fresh catalysts, with several companies in focus for Q1 results. Tech Mahindra reported a signi...
- Stocks in news: TCS, Akzo Nobel, Indosolar, Emcure Pharma, Enviro InfraMarkets experienced volatility within a tight range, closing slightly lower, continuing the consolidation trend. TCS is set to release its ...
- Stocks in news: Vedanta, RBL Bank, Bajaj Finance, RIL, MaricoMarkets experienced volatility on the weekly expiry day, closing marginally lower amidst ongoing consolidation. Vedanta reported strong Q1F...
- Emcure Pharma shares jump over 4% post listing. Should you buy, sell or hold?Pune-based Emcure Pharmaceuticals listed at Rs 1,325, a 31.4% premium on Rs 1,008 IPO price. QIBs subscribed 195.8 times, non-institutional...
- Emcure Pharma shares debut with 31% premium over issue priceBefore listing, the company's shares traded at a Rs 360 premium in the grey market. It raised Rs 582 crore from anchor investors, including...
- Emcure Pharma IPO GMP: Street anticipates a robust listing tomorrow. Will it trump expectations?Emcure Pharmaceuticals' shares to debut on stock exchanges with a GMP of Rs 360. Analysts bullish on both short-term and long-term gains. C...
- Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid?Emcure Pharma IPO: Emcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity issuance and OFS. Namita Th...
- Shark tank fame Namita Thapar to rake in Rs 127 crore through Emcure Pharma IPOShark Tank's Namita Thapar, who is part of Emcure Pharmaceuticals' promoter group, is set to earn approximately Rs 127 crore through the up...
- What should investors do with HDFC Bank stocks? Rahul Shah answersSo, a good IPO and the way they have priced it also, as you rightly said, that very reasonably priced and some money to be made on the tabl...
- Emcure Pharmaceuticals IPO: 10 things to know before subscribing to the issueEmcure Pharmaceuticals IPO is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximatel...
- Mankind Pharma files DRHP for Rs 5,500 crore IPOThe company’s initial public offering comprises an offer for the sale of 4 crore equity shares by the promoters and existing investors.The ...
- Mankind Pharma plans $1 billion IPO, hires bankersIn the proposed offer for sale, existing investors ChrysCapital will sell about 1% stake, Capital International will sell another 6% while ...
- Emcure Pharma's Rs 5,000 cr-IPO to hit market early next monthThe IPO consists of a fresh issue of up to Rs 1,100 crore by the company, which will be used as growth capital
- US generics probe reveals startling detail of price fixing in Doxycycline and GlyburideA Bloomberg report said two executives of Heritage Pharma – the US arm of Indian drug maker Emcure - are preparing to plead guilty to price...
- Pharma majors urges for separate zone in J&K to tap bigger off shore marketsPharma majors operating manufacturing facilities in Jammu want a separate, cleaner zone to enable them tapping better and bigger off shore ...
- Stocks to watch: Zydus Cadilla, JP Associates, JSW Steel, MTNL, RIL, Tata Steel, MMTC, Take SolutionsPfizer has approached several Indian drugmakers for possible alliances as part of moves to try and bolster revenues threatened by the expir...
Load More
